Granulocyte colony-stimulating factor inhibits neutrophil apoptosis at the local site after severe head and thoracic injury.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 10338394)

Published in J Trauma on May 01, 1999

Authors

W Ertel1, M Keel, U Buergi, T Hartung, H G Imhof, O Trentz

Author Affiliations

1: Division of Trauma Surgery, University Hospital Zurich, Switzerland.

Articles by these authors

Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med (2001) 3.09

Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol (2001) 2.36

Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood (1995) 2.20

Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med (2000) 2.19

Supracerebellar transtentorial approach to posterior temporomedial structures. J Neurosurg (2001) 2.13

Artifactual pulse-oximetry estimation in neonates. Lancet (1994) 2.04

The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J Biol Chem (2001) 2.04

Control of severe hemorrhage using C-clamp and pelvic packing in multiply injured patients with pelvic ring disruption. J Orthop Trauma (2001) 1.93

Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J Cereb Blood Flow Metab (2000) 1.78

Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury. Neurology (2005) 1.76

Ultrasound in blunt abdominal and thoracic trauma. J Trauma (1993) 1.75

Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur J Immunol (2001) 1.68

Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. J Immunol (1992) 1.60

Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood (1997) 1.58

Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation. J Biol Chem (2001) 1.49

Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron (1986) 1.47

[The abdominal compartment syndrome]. Unfallchirurg (2001) 1.41

Improved innate immunity of endotoxin-tolerant mice increases resistance to Salmonella enterica serovar typhimurium infection despite attenuated cytokine response. Infect Immun (2001) 1.40

Incidence of septic complications and multiple organ failure in severely injured patients is sex specific. J Trauma (2000) 1.40

IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neuroimmunol (1999) 1.39

Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Mol Psychiatry (1997) 1.35

Incidence and clinical pattern of the abdominal compartment syndrome after "damage-control" laparotomy in 311 patients with severe abdominal and/or pelvic trauma. Crit Care Med (2000) 1.32

Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res (2001) 1.32

Selective extradural anterior clinoidectomy for supra- and parasellar processes. Technical note. J Neurosurg (1997) 1.29

Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma (1997) 1.28

The terminal vascular bed in the superficial cortex of the rat. An SEM study of corrosion casts. J Neurosurg (1986) 1.27

Roles of histamine, complement and xanthine oxidase in thermal injury of skin. Am J Pathol (1989) 1.27

Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. J Immunol (1997) 1.26

Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg (1997) 1.24

Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney Int (1997) 1.22

Posterior elbow dislocation with associated vascular injury after blunt trauma. J Trauma (1999) 1.20

Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med (1999) 1.19

Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures. Acta Neurochir (Wien) (2003) 1.15

S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma (2001) 1.15

Continuous noninvasive measurement of cerebral arterial and venous oxygen saturation at the bedside in mechanically ventilated neonates. Crit Care Med (1997) 1.14

A new mechanism for IL-5-dependent helminth control: neutrophil accumulation and neutrophil-mediated worm encapsulation in murine filariasis are abolished in the absence of IL-5. Int Immunol (2000) 1.13

Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. Blood (2000) 1.13

Sucrose reduces pain reaction to heel lancing in preterm infants: a placebo-controlled, randomized and masked study. Pediatr Res (1995) 1.12

Cell activation and inflammatory response following traumatic axonal injury in the rat. Neuroreport (2000) 1.10

Toward an evidence-based toxicology. Hum Exp Toxicol (2006) 1.09

Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab (1997) 1.09

Characteristics of surfactant protein A and D binding to lipoteichoic acid and peptidoglycan, 2 major cell wall components of gram-positive bacteria. J Infect Dis (2001) 1.08

Whole blood cytokine response as a measure of immunotoxicity. Toxicol In Vitro (2001) 1.08

Inflammatory and immunological parameters in children with haemolytic uremic syndrome (HUS) and gastroenteritis-pathophysiological and diagnostic clues. Cytokine (2000) 1.07

Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock (1995) 1.06

Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res (1996) 1.06

Formation of free radicals and nitric oxide derivative of hemoglobin in rats during shock syndrome. Free Radic Res Commun (1990) 1.05

Upregulation of ICAM-1 and MCP-1 but not of MIP-2 and sensorimotor deficit in response to traumatic axonal injury in rats. J Neurosci Res (2001) 1.05

The use of a retractor system (SynFrame) for open, minimal invasive reconstruction of the anterior column of the thoracic and lumbar spine. Eur Spine J (2001) 1.05

Different pattern of local and systemic release of proinflammatory and anti-inflammatory mediators in severely injured patients with chest trauma. J Trauma (1996) 1.04

Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma (1995) 1.02

Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res (2000) 1.02

TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function. J Neurotrauma (1999) 1.02

Distal posterior inferior cerebellar artery aneurysms: clinical characteristics and surgical management. Acta Neurochir (Wien) (2005) 1.02

Review of typical ice hockey injuries. Survey of the North American NHL and Hockey Canada versus European leagues. Unfallchirurg (1995) 1.01

Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury. J Neurotrauma (2001) 1.01

Control of fecal peritoneal infection in mice by colony-stimulating factors. J Infect Dis (1996) 1.00

Interleukin-18 plasma levels are increased in patients with sepsis compared to severely injured patients. Shock (2001) 1.00

Circulating mediators in serum of injured patients with septic complications inhibit neutrophil apoptosis through up-regulation of protein-tyrosine phosphorylation. J Trauma (1998) 1.00

Outcome after acute extradural haematoma, influence of additional injuries and neurological complications in the ICU. Injury (1996) 0.99

In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor. J Immunol (1997) 0.98

Are unilateral right posterior cerebral lesions sufficient to cause prosopagnosia? Clinical and radiological findings in six additional patients. Cortex (1986) 0.98

Endotoxin tolerance-mechanisms and beneficial effects in bacterial infection. Rev Physiol Biochem Pharmacol (2002) 0.98

cGMP-mediated inhibition of TNF-alpha production by the atrial natriuretic peptide in murine macrophages. J Immunol (2000) 0.97

Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra) on human osteoblasts in vitro. Br J Surg (2005) 0.96

Modulation of cytokine release in ex vivo-stimulated blood from borreliosis patients. Infect Immun (2001) 0.95

The effects of solvents on embryonic stem cell differentiation. Toxicol In Vitro (2005) 0.95

Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood-brain barrier disruption through glia activation: role of pro-inflammatory cytokines and nitric oxide. Neuroscience (2005) 0.94

Prediction of psychiatric morbidity in severely injured accident victims at one-year follow-up. Am J Respir Crit Care Med (2001) 0.94

sICAM-1 and TNF-alpha induce MIP-2 with distinct kinetics in astrocytes and brain microvascular endothelial cells. J Neurosci Res (2000) 0.94

[Distraction spondylodesis of the sacrum in "vertical shear lesions" of the pelvis]. Unfallchirurg (1994) 0.94

Inhibition of caspase activity prevents CD95-mediated hepatic microvascular perfusion failure and restores Kupffer cell clearance capacity. FASEB J (1999) 0.94

Bruton's tyrosine kinase together with PI 3-kinase are part of Toll-like receptor 2 multiprotein complex and mediate LTA induced Toll-like receptor 2 responses in macrophages. Cell Signal (2006) 0.93

Conversion of L-thyroxine to triiodothyronine in rat kidney homogenate. Endocrinology (1978) 0.93

Intracerebral complement C5a receptor (CD88) expression is regulated by TNF and lymphotoxin-alpha following closed head injury in mice. J Neuroimmunol (2000) 0.93

Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: rapid induction of Th1-type cytokines and inducible nitric oxide synthase. J Immunol (2000) 0.93

Soluble ICAM-1 in CSF coincides with the extent of cerebral damage in patients with severe traumatic brain injury. J Neurotrauma (1998) 0.92

Immune protection against septic peritonitis in endotoxin-primed mice is related to reduced neutrophil apoptosis. Eur J Immunol (2001) 0.91

Temporal sequence of pulmonary and systemic inflammatory responses to graded polymicrobial peritonitis in mice. Infect Immun (1999) 0.91

Structures in Bacillus subtilis are recognized by CD14 in a lipopolysaccharide binding protein-dependent reaction. Infect Immun (1999) 0.91

Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cerebrospinal fluid. J Cereb Blood Flow Metab (1999) 0.91

Role of xanthine oxidase in thermal injury of skin. Am J Pathol (1989) 0.91

Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after polytrauma and burn. Clin Chem Lab Med (1998) 0.91

Cardiopulmonary parameters and prognosis after severe multiple trauma. J Trauma (1979) 0.90

Endotoxin tolerance after severe injury and its regulatory mechanisms. J Trauma (1996) 0.90

In vivo and in vitro evidence for extracellular caspase activity released from apoptotic cells. Biochem Biophys Res Commun (2001) 0.90

The influence of a clear layer on near-infrared spectrophotometry measurements using a liquid neonatal head phantom. Phys Med Biol (1999) 0.89

Increased release of soluble tumor necrosis factor receptors into blood during clinical sepsis. Arch Surg (1994) 0.89

[Combined surgery for fractures of the thoraco-lumbar junction using the inlay-span method]. Orthopade (1999) 0.89

Differential effect of caspase inhibition on proinflammatory cytokine release in septic patients. Shock (2000) 0.88